Gut Microbiota in Chronic Kidney Disease: From Composition to Modulation towards Better Outcomes—A Systematic Review

Abstract

Background: A bidirectional kidney–gut axis was described in patients with chronic kidney disease (CKD). On the one hand, gut dysbiosis could promote CKD progression, but on the other hand, studies reported specific gut microbiota alterations linked to CKD. Therefore, we aimed to systematically review the literature on gut microbiota composition in CKD patients, including those with advanced CKD stages and end-stage kidney disease (ESKD), possibilities to shift gut microbiota, and its impact on clinical outcomes. Materials and methods: We performed a literature search in MEDLINE, Embase, Scopus, and Cochrane databases to find eligible studies using pre-specified keywords. Additionally, key inclusion and exclusion criteria were pre-defined to guide the eligibility assessment. Results: We retrieved 69 eligible studies which met all inclusion criteria and were analyzed in the present systematic review. Microbiota diversity was decreased in CKD patients as compared to healthy individuals. Ruminococcus and Roseburia had good power to discriminate between CKD patients and healthy controls (AUC = 0.771 and AUC = 0.803, respectively). Roseburia abundance was consistently decreased in CKD patients, especially in those with ESKD (p < 0.001). A model based on 25 microbiota dissimilarities had an excellent predictive power for diabetic nephropathy (AUC = 0.972). Several microbiota patterns were observed in deceased ESKD patients as compared to the survivor group (increased Lactobacillus, Yersinia, and decreased Bacteroides and Phascolarctobacterium levels). Additionally, gut dysbiosis was associated with peritonitis and enhanced inflammatory activity. In addition, some studies documented a beneficial effect on gut flora composition attributed to synbiotic and probiotic therapies. Large randomized clinical trials are required to investigate the impact of different microbiota modulation strategies on gut microflora composition and subsequent clinical outcomes. Conclusions: Patients with CKD had an altered gut microbiome profile, even at early disease stages. Different abundance at genera and species levels could be used in clinical models to discriminate between healthy individuals and patients with CKD. ESKD patients with an increased mortality risk could be identified through gut microbiota analysis. Modulation therapy studies are warranted.

Causal relationship in gut microbiota and upper urinary urolithiasis using Mendelian randomization

“…The gut microbiota is the largest micro-ecosystem of the human body, participating in and influencing the metabolism of the substance and energy (Anand and Mande, 2022 ). Crosstalk between the gut microbiome and kidney has been widely documented, for example, intestinal ecological disorders are often found in patients with chronic kidney disease (Voroneanu et al, 2023 ). The role of gut microbiome in the pathogenesis of kidney stones has also attracted more and more attention.…”

Can Nutrition Contribute to a Reduction in Sarcopenia, Frailty, and Comorbidities in a Super-Aged Society?

“…Prebiotics and probiotics enhance the effect of dietary fiber. Dysbiosis, which is defined as the impairment of microbiota composition and gut barrier integrity, associates with many chronic diseases, including diabetes mellitus [256] and CKD [257]. We expected to find evidence of the potential benefits that dietary fiber, prebiotics, and probiotics have for various health conditions, particularly by improving dysbiosis in CKD patients.…”

Can Nutrition Contribute to a Reduction in Sarcopenia, Frailty, and Comorbidities in a Super-Aged Society?

“…Prebiotics and probiotics enhance the effect of dietary fiber. Dysbiosis, which is defined as the impairment of microbiota composition and gut barrier integrity, is associated with many chronic diseases, including diabetes mellitus [253] and CKD [254]. We expected to find evidence of the potential benefits that dietary fiber, prebiotics, and probiotics have for various health conditions, particularly by improving dysbiosis in CKD patients.…”